7 April 2025 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on seven medicines.

Alectinib hydrochloride (Alecensa) was accepted to treat adults with a rare type of lung cancer, known as ALK-positive non-small cell lung cancer, who are at high risk of recurrence following surgery.

Read SMC press release